N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide

C79H86N18O6 — CID 159928125

IUPACN-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide
SMILESCc1c(Cc2ccc(-c3ccn(C)n3)cc2)cc(C(=O)N[C@H]2CCC[C@@H]2O)nc1-n1cccn1.Cn1cc(-c2cc(Cc3ccc(-c4ccn(C)n4)cc3)cc(C(=O)N[C@H]3CCCC[C@@H]3O)n2)cn1.Cn1ccc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cc2)n1
InChIInChI=1S/C27H30N6O2.2C26H28N6O2/c1-32-12-11-22(31-32)20-9-7-18(8-10-20)13-19-14-24(21-16-28-33(2)17-21)29-25(15-19)27(35)30-23-5-3-4-6-26(23)34;1-17-20(15-18-7-9-19(10-8-18)21-11-14-31(2)30-21)16-23(28-25(17)32-13-4-12-27-32)26(34)29-22-5-3-6-24(22)33;1-31-14-11-21(30-31)20-9-7-18(8-10-20)15-19-16-23(28-25(17-19)32-13-4-12-27-32)26(34)29-22-5-2-3-6-24(22)33/h7-12,14-17,23,26,34H,3-6,13H2,1-2H3,(H,30,35);4,7-14,16,22,24,33H,3,5-6,15H2,1-2H3,(H,29,34);4,7-14,16-17,22,24,33H,2-3,5-6,15H2,1H3,(H,29,34)/t23-,26-;2*22-,24-/m000/s1
InChIKeyNZHABYQJTXUHTL-YSQIDGTQSA-N
MW1383.68 g/mol
LogP10.01
Rot. Bonds18

About N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide

N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide (PubChem CID 159928125) has the molecular formula C79H86N18O6 and a molecular weight of 1383.68 g/mol. Its IUPAC name is N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide.

Molecular Properties

Compound NameN-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide
PubChem CID159928125
Molecular FormulaC79H86N18O6
Molecular Weight1383.68 g/mol
Exact Mass1382.70
IUPAC NameN-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide
SMILESCc1c(Cc2ccc(-c3ccn(C)n3)cc2)cc(C(=O)N[C@H]2CCC[C@@H]2O)nc1-n1cccn1.Cn1cc(-c2cc(Cc3ccc(-c4ccn(C)n4)cc3)cc(C(=O)N[C@H]3CCCC[C@@H]3O)n2)cn1.Cn1ccc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cc2)n1
InChIInChI=1S/C27H30N6O2.2C26H28N6O2/c1-32-12-11-22(31-32)20-9-7-18(8-10-20)13-19-14-24(21-16-28-33(2)17-21)29-25(15-19)27(35)30-23-5-3-4-6-26(23)34;1-17-20(15-18-7-9-19(10-8-18)21-11-14-31(2)30-21)16-23(28-25(17)32-13-4-12-27-32)26(34)29-22-5-3-6-24(22)33;1-31-14-11-21(30-31)20-9-7-18(8-10-20)15-19-16-23(28-25(17-19)32-13-4-12-27-32)26(34)29-22-5-2-3-6-24(22)33/h7-12,14-17,23,26,34H,3-6,13H2,1-2H3,(H,30,35);4,7-14,16,22,24,33H,3,5-6,15H2,1-2H3,(H,29,34);4,7-14,16-17,22,24,33H,2-3,5-6,15H2,1H3,(H,29,34)/t23-,26-;2*22-,24-/m000/s1
InChIKeyNZHABYQJTXUHTL-YSQIDGTQSA-N
XLogP10.01
TPSA293.58 Ų
H-Bond Donors6
H-Bond Acceptors21
Rotatable Bonds18
Heavy Atoms103
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001383.68
LogP ≤ 510.01
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1021

Analyze N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The IUPAC name of N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide (CID 159928125) is N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide.
What is the SMILES notation for N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The canonical SMILES for N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide is Cc1c(Cc2ccc(-c3ccn(C)n3)cc2)cc(C(=O)N[C@H]2CCC[C@@H]2O)nc1-n1cccn1.Cn1cc(-c2cc(Cc3ccc(-c4ccn(C)n4)cc3)cc(C(=O)N[C@H]3CCCC[C@@H]3O)n2)cn1.Cn1ccc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cc2)n1.
What is the InChIKey of N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The InChIKey is NZHABYQJTXUHTL-YSQIDGTQSA-N. The full InChI is InChI=1S/C27H30N6O2.2C26H28N6O2/c1-32-12-11-22(31-32)20-9-7-18(8-10-20)13-19-14-24(21-16-28-33(2)17-21)29-25(15-19)27(35)30-23-5-3-4-6-26(23)34;1-17-20(15-18-7-9-19(10-8-18)21-11-14-31(2)30-21)16-23(28-25(17)32-13-4-12-27-32)26(34)29-22-5-3-6-24(22)33;1-31-14-11-21(30-31)20-9-7-18(8-10-20)15-19-16-23(28-25(17-19)32-13-4-12-27-32)26(34)29-22-5-2-3-6-24(22)33/h7-12,14-17,23,26,34H,3-6,13H2,1-2H3,(H,30,35);4,7-14,16,22,24,33H,3,5-6,15H2,1-2H3,(H,29,34);4,7-14,16-17,22,24,33H,2-3,5-6,15H2,1H3,(H,29,34)/t23-,26-;2*22-,24-/m000/s1.
What are the key properties of N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide has a molecular weight of 1383.68 g/mol, XLogP of 10.01, 18 rotatable bonds, 6 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S,2S)-2-hydroxycyclohexyl]-6-(1-methylpyrazol-4-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-5-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide is sourced from PubChem (CID 159928125), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).